Data Completion
Participant retention rate to hospital discharge was 100%. Two-week and 2-month follow-up completion rates were 84.5% and 87.5%, respectively (Feasibility OutcomesData in parentheses are 95% confidence intervals.Responders are those screened but not eligible because they did not have a residual collection on Day 1 or C-reactive protein level decreased by more than half.Randomized among actual number eligible.Number who completed hospital discharge/number of survivors.Number who completed 2 weeks/number of survivors to 2 weeks after discharge.The HADS was implemented during the inpatient phase 1–2 days after randomization, and the completion rate was 93% (20 of 21 [standard care], 18 of 19 [IET], and 18 of 20 [VATS]). At 2-week follow-up, completion rates of the IPAQ and EQ-5D-5 L questionnaire were 79% and 81%, respectively. Completion rates of both the IPAQ and EQ-5D-5 L questionnaire at 2 months and 6 months were 84% and 71%, respectively. Analysis was performed for the ITT population using available cases, with unacceptable values set to missing.